15 N NMR Hyperpolarization of Radiosensitizing Antibiotic Nimorazole by Reversible Parahydrogen Exchange in Microtesla Magnetic Fields.
Oleg G SalnikovNikita V ChukanovAlexandra I TrepakovaIvan A TrofimovMohammad S H KabirJuri George GelovaniKirill V KovtunovIgor V KoptyugEduard Y ChekmenevPublished in: Angewandte Chemie (International ed. in English) (2020)
Nimorazole belongs to the imidazole-based family of antibiotics to fight against anaerobic bacteria. Moreover, nimorazole is now in Phase 3 clinical trial in Europe for potential use as a hypoxia radiosensitizer for treatment of head and neck cancers. We envision the use of [15 N3 ]nimorazole as a theragnostic hypoxia contrast agent that can be potentially deployed in the next-generation MRI-LINAC systems. Herein, we report the first steps to create long-lasting (for tens of minutes) hyperpolarized state on three 15 N sites of [15 N3 ]nimorazole with T1 of up to ca. 6 minutes. The nuclear spin polarization was boosted by ca. 67000-fold at 1.4 T (corresponding to P15N of 3.2 %) by 15 N-15 N spin-relayed SABRE-SHEATH hyperpolarization technique, relying on simultaneous exchange of [15 N3 ]nimorazole and parahydrogen on polarization transfer Ir-IMes catalyst. The presented results pave the way to efficient spin-relayed SABRE-SHEATH hyperpolarization of a wide range of imidazole-based antibiotics and chemotherapeutics.
Keyphrases
- room temperature
- clinical trial
- density functional theory
- magnetic resonance
- single molecule
- contrast enhanced
- magnetic resonance imaging
- endothelial cells
- high resolution
- transition metal
- ionic liquid
- randomized controlled trial
- open label
- study protocol
- highly efficient
- computed tomography
- mass spectrometry
- human health
- phase iii
- carbon dioxide
- gold nanoparticles
- reduced graphene oxide